Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2005
06/08/2005EP1537857A1 Mupirocin compositions for topical use, a process of making same and uses thereof
06/08/2005EP1537237A2 Use of pp2a phosphatase modulators in the treatment of mental disorders
06/08/2005EP1537208A1 Non-sequence complementary antiviral oligonucleotides
06/08/2005EP1537138A2 Receptors and membrane-associated proteins
06/08/2005EP1537135A2 Adenosine a3 receptor agonists
06/08/2005EP1537129A1 Akt inhibitors, pharmaceutical compositions, and uses thereof
06/08/2005EP1537124A1 C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
06/08/2005EP1537122A1 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
06/08/2005EP1537121A1 Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans
06/08/2005EP1537118A1 Oxycodone-hydrochloride polymorhs
06/08/2005EP1537115A1 Selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders
06/08/2005EP1537113A1 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
06/08/2005EP1537110A2 Triazospiro compounds having nociceptin receptor affinity
06/08/2005EP1537106A1 Dihydropyrazolopyridine compounds
06/08/2005EP1537104A1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist
06/08/2005EP1537103A1 Antidepressant cycloalkylamine derivates of 2,3-dihydro-1,4-benzodioxan
06/08/2005EP1537096A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
06/08/2005EP1537090A1 Chromone derivatives as matrix metalloproteinase inhibitors
06/08/2005EP1537087A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
06/08/2005EP1537086A2 Novel phenanthridines
06/08/2005EP1537073A2 Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
06/08/2005EP1537072A1 Substituted aminoethers for the treatment of alzheimer s disease
06/08/2005EP1537066A2 Improvements in pharmaceutically useful compounds
06/08/2005EP1536839A2 Method for treating diseases with omega interferon
06/08/2005EP1536813A2 Compositions and methods comprising protein activated receptor antagonists
06/08/2005EP1536801A2 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/08/2005EP1536797A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough
06/08/2005EP1536792A1 Pramipexole once-daily dosage form
06/08/2005EP1536791A1 Sustained-release tablet comprising reboxetine
06/08/2005EP1536790A2 Oxadiazoles as modulators of metabotropic glutamate receptor-5
06/08/2005EP1536782A1 Synergistic combination of an alpha-2-delta ligand and a pdev inhibitor for use in the treatment of pain
06/08/2005EP1536778A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity
06/08/2005EP1458706A4 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
06/08/2005EP1440075B1 Novel 3beta-amino azabicyclooctane heteroaromatic amide derivatives, preparation method and therapeutic uses thereof
06/08/2005EP1414937B1 Hops extracts, method for the production and use
06/08/2005EP1373269B1 Jun kinase inhibitors
06/08/2005EP1370528B1 Mch antagonists and their use in the treatment of obesity
06/08/2005EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators
06/08/2005EP1294710B1 Indole derivatives useful for the treatment of cns disorders
06/08/2005EP1259514B1 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
06/08/2005EP1252133B1 Pharmaceutical compounds
06/08/2005EP1239844B1 Process for producing nanometer particles by fluid bed spray-drying
06/08/2005EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors
06/08/2005EP1189895B1 Thiazole and oxazole derivatives and their pharmaceutical use
06/08/2005EP1176146B1 Carbamoyl tetrahydropyridine derivatives
06/08/2005EP1089735B1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists
06/08/2005EP1024806B1 Use of non-immunosuppressive compounds for promoting nerve regeneration
06/08/2005EP1017391B1 Sustained release tablet formulation to treat parkinson disease
06/08/2005EP1001797B1 Soya extract, process for its preparation and pharmaceutical composition
06/08/2005EP0922029B1 Ether muscarinic antagonists
06/08/2005CN1625603A Genetic polymorphisms in the preprotachykinin gene
06/08/2005CN1625564A Tolerogenic peptides from myelin basic protein
06/08/2005CN1625558A Aza-arylpiperazines
06/08/2005CN1625557A Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
06/08/2005CN1625556A Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
06/08/2005CN1625554A Amides of aminoalkyl substituted azetidines, pyrrolidines, piperidines and azepanes
06/08/2005CN1625410A 2, 4, 6-triamino-1, 3, 5-triazine derivative
06/08/2005CN1625408A Improved kavalactone profile
06/08/2005CN1625406A Formulation containing (lyso-) phosphatidylserine for the prevention and treatment of stress states in warm-blooded animals
06/08/2005CN1625404A Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of cardiovascular conditions
06/08/2005CN1625401A Non-sedating barbituric acid derivatives
06/08/2005CN1624128A Death domain containing receptor 5 antibodies
06/08/2005CN1624126A Ret ligand (retl) for stimulating neural and renal growth
06/08/2005CN1623599A Xiaoyao soft capsule and its preparation technology
06/08/2005CN1623598A Volatile extraction for promoting falling asleep and improving sleep quality and its product for external use
06/08/2005CN1623593A Solid instant preparation extracted from ginkgo leaf and its preparing process
06/08/2005CN1623591A Composition of pharmaceutical and preparation process thereof
06/08/2005CN1623581A Medicine for preventing and treating brain traumatic reaction syndrome
06/08/2005CN1623548A Galanthamine slow release preparation and its preparation method
06/08/2005CN1623547A Medical use of artificial lywrine
06/08/2005CN1205335C Tumor death induction ligand gene, gene expression protein and is preparation method
06/08/2005CN1205220C Novel cyclosporins
06/08/2005CN1205210C 9-azabicyclo (3,3,1) non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ACH receptors
06/08/2005CN1205207C Substituted indolealkanoic acids
06/08/2005CN1205203C Synthesis method of medicine for curing senile dementia
06/08/2005CN1205193C Crystalline form of 4-[5-methyl-3-phenylisoxazol)-4-yl] benzenesulfonamide
06/08/2005CN1205188C 4,5-dihydro-1h-pyrazole derivatives having CB1-antagonistic activity
06/08/2005CN1205181C Matrix metalloproteinase inhibitors
06/08/2005CN1205176C Stable salts of o-acetylsalicyclic with basic amino acids
06/08/2005CN1204916C Medicine for treating depression and its preparation method
06/08/2005CN1204898C Chinese medicine for dropping drug and giving up addiction, made of natural plant
06/08/2005CN1204891C Injection containing tramadol and its application
06/08/2005CN1204890C Method for preventing abuse of opioid dosage forms
06/08/2005CN1204875C Delivery system for oral care compositions comprising organosiloxane resins using removable backing strip
06/07/2005US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/07/2005US6903188 Isolated functional derivative of an Mts protein that is preferably a multimeric protein complex.
06/07/2005US6903187 Structural modification of clostridal neurotoxins including addition or deletion of a leucine-based motif to treat biological disorders include treating autonomic disorders, neuromuscular disorders and pain
06/07/2005US6903186 Analogues of GLP-1
06/07/2005US6903137 Agonists specific for the peripheral cannabinoid receptor
06/07/2005US6903132 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
06/07/2005US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer
06/07/2005US6903130 (S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide stereoisomer for the treatment of bipolar disorders
06/07/2005US6903129 D-proline prodrugs
06/07/2005US6903128 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
06/07/2005US6903123 Antitussive agents, anxiolytic agents, analgesics for treating cough, anxiety and pain
06/07/2005US6903120 Modulators of dopamine neurotransmission
06/07/2005US6903115 Bipiperidine compounds
06/07/2005US6903114 Carbocyclic alcohols such as 1,6-dinitronaphthalene-2,3-diol, used as catechol-O-methyltransferase inhibitors, for prophylaxis of Parkinson's disease
06/07/2005US6903112 Nitrogen compounds such as 1-benzenesulfonyl-3-piperidin-3-yl -1H-indole, used as serotonin receptor antagonists, for prophylaxis of nervous system disorders
06/07/2005US6903110 Selective serotonin reuptake inhibitors
1 ... 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 ... 1833